LLY

956.53

+0.79%↑

NVO

142.49

+0.22%↑

UNH

517.8

+1.13%↑

JNJ

149.2

-0.41%↓

MRK

128.02

+0.5%↑

LLY

956.53

+0.79%↑

NVO

142.49

+0.22%↑

UNH

517.8

+1.13%↑

JNJ

149.2

-0.41%↓

MRK

128.02

+0.5%↑

LLY

956.53

+0.79%↑

NVO

142.49

+0.22%↑

UNH

517.8

+1.13%↑

JNJ

149.2

-0.41%↓

MRK

128.02

+0.5%↑

LLY

956.53

+0.79%↑

NVO

142.49

+0.22%↑

UNH

517.8

+1.13%↑

JNJ

149.2

-0.41%↓

MRK

128.02

+0.5%↑

LLY

956.53

+0.79%↑

NVO

142.49

+0.22%↑

UNH

517.8

+1.13%↑

JNJ

149.2

-0.41%↓

MRK

128.02

+0.5%↑

Search

ACADIA Pharmaceuticals Inc

Avatud

Sektor Tervishoid

17.98 1.07

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.54

Max

18.15

Põhinäitajad

By Trading Economics

Sissetulek

-29M

17M

Müük

-25M

206M

Aktsiakasum

0.1

Kasumimarginaal

8.044

Töötajad

597

EBITDA

-16M

21M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+54.19 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

31. juuli 2024

Turustatistika

By TradingEconomics

Turukapital

-6.6M

2.7B

Eelmine avamishind

16.91

Eelmine sulgemishind

17.98

Uudiste sentiment

By Acuity

100%

0%

343 / 369 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

ACADIA Pharmaceuticals Inc Graafik

Seotud uudised

12. juuli 2024, 22:05 UTC

Omandamised, ülevõtmised, äriostud

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110 Million

12. juuli 2024, 20:18 UTC

Omandamised, ülevõtmised, äriostud

Lundin Mining Approaches BHP to Buy Copper Miner Filo, Bloomberg Reports

12. juuli 2024, 19:57 UTC

Suurimad hinnamuutused turgudel

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

12. juuli 2024, 18:13 UTC

Peamised uudised

Elon Musk's X Found in Breach of EU Digital-Content Law -- 2nd Update

14. juuli 2024, 23:32 UTC

Market Talk

Macquarie's Asset Management Unit May Be a Drag -- Market Talk

14. juuli 2024, 22:41 UTC

Tulu

Stocks Poised for Higher Open -- Barrons.com

14. juuli 2024, 22:38 UTC

Market Talk

New Zealand Housing Market Likely to Stay on Back Foot -- Market Talk

14. juuli 2024, 22:30 UTC

Omandamised, ülevõtmised, äriostud

Paladin: Gets Canadian Competition Act Clearance for Fission Uranium Acquisition

14. juuli 2024, 22:28 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. juuli 2024, 22:28 UTC

Market Talk

ANZ Worries Downgrade to NZ House-Price Forecast Wasn't Deep Enough -- Market Talk

14. juuli 2024, 21:15 UTC

Tulu

Goldman Sachs Earnings: Wall Street Is Looking for Signs of Revival in Dealmaking -- Barrons.com

14. juuli 2024, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Google Nears $23 Billion Deal to Acquire Cybersecurity Firm Wiz: WSJ -- Barrons.com

14. juuli 2024, 16:56 UTC

Omandamised, ülevõtmised, äriostud

Google Near $23 Billion Deal for Cybersecurity Startup Wiz -- WSJ

14. juuli 2024, 11:42 UTC

Omandamised, ülevõtmised, äriostud

Pork Producer Smithfield Plans Return to Equity U.S. Markets -- WSJ

13. juuli 2024, 12:00 UTC

Peamised uudised
Tulu

Rate Cuts Could Make Things Worse for Banks Before They Help -- Heard on the Street -- WSJ

13. juuli 2024, 01:19 UTC

Peamised uudised

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- 3rd Update

12. juuli 2024, 23:29 UTC

Omandamised, ülevõtmised, äriostud

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

12. juuli 2024, 21:50 UTC

Omandamised, ülevõtmised, äriostud

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110M

12. juuli 2024, 21:03 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

The Score: Microsoft, Delta Air Lines, Wells Fargo and More Stocks That Defined the Week -- WSJ

12. juuli 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

12. juuli 2024, 20:41 UTC

Peamised uudised

Dow Rises With Investors Putting Rate Cut in Sight -- WSJ

12. juuli 2024, 20:38 UTC

Omandamised, ülevõtmised, äriostud

Ansys: Synopsys Submits Notification of Transaction to China Regulator for Purchase of Ansys

12. juuli 2024, 20:26 UTC

Peamised uudised
Tulu

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12. juuli 2024, 20:19 UTC

Tulu

These Stocks Moved the Most Today: Tesla, Wells Fargo, JPMorgan, BNY, Nvidia, and More -- Barrons.com

12. juuli 2024, 19:26 UTC

Tulu

Correction to Big Banks Continue to Feel Pressure From Higher Rates Article -- WSJ

12. juuli 2024, 19:07 UTC

Market Talk

U.S. Natural Gas Futures Snap 3-Day Losing Streak -- Market Talk

12. juuli 2024, 17:52 UTC

Peamised uudised
Tulu

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12. juuli 2024, 17:34 UTC

Market Talk

Gold Takes Pause After Surge -- Market Talk

12. juuli 2024, 17:31 UTC

Market Talk

U.S. Oil Rig Count Down By 1 to 478 -- Market Talk

12. juuli 2024, 17:22 UTC

Market Talk

Private-Capital Investing For Solar Developers Dropped in 1H -- Market Talk

Võrdlus sarnastega

Hinnamuutus

ACADIA Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

54.19% tõus

12 kuu keskmine prognoos

Keskmine 27.4 USD  54.19%

Kõrge 39 USD

Madal 17 USD

Põhineb 15 Wall Streeti analüütiku instrumendi ACADIA Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

11

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

15.89 / 17.96Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

$

Ettevõttest ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).